Navigation Links
First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

utility and cost-effectiveness. The model design took into account disease modifying therapy (DMT) acquisition costs, state-specific MS-related medical costs and the cost of lost worker productivity.

The analysis found that the total cost per patient over the time horizon of a patient's lifetime for COPAXONE(R) was estimated to be 34.7 percent, 16.8 percent and 14.5 percent less than Rebif(R), Betaseron(R) and Avonex(R), respectively. Sensitivity analyses showed the results to be sensitive to changes in health state utilities, the percentage reduction in disease progression rates as measured by EDSS in the first two years of therapy used to estimate immunomodulatory therapy treatment effects, model time horizon and immunomodulatory therapy acquisition costs.

The authors of this study note that limitations included reliance on clinical trial data, no inclusion of cost and utilities associated with adverse events, assumptions surrounding the discontinuation and switching of therapies and estimation of clinical outcomes, lack of sufficient head-to-head clinical trials and clinical trial relapse rate criteria associated with this analysis.

About MS

MS is a chronic neurodegenerative inflammatory disease of the central nervous system with an overall prevalence rate of approximately 400,000 people. The annual cost of MS (in 1994 $US) is estimated to be between $6.8 and $13.6 billion, composed largely of indirect costs for formal/informal care and lost earnings. Previous research finds that costs associated with MS rise at an exponential rate with increasing MS disability levels.

About COPAXONE(R)

Current data suggest COPAXONE(R) is a selective MHC class II modulator. COPAXONE(R) is indicated for the reduction of the frequency of relapses in RRMS. The most common side effects of COPAXONE(R) are redness, pain, swelling, itching, a lump or an indentation at the site of injection, weakness, infection, pain, nausea, joint pain, anxiety,
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model

Post Your Comments:
(Date:11/6/2009)... DIEGO, Nov. 6 California American... as "No Drugs Down the Drain" week for its San Die...ign sponsored by public and private agencies alike...cal pollution in our source water supplies. ,, ...mers are encouraged to drop off expired or unwante...
(Date:11/5/2009)... DIEGO, Nov. 5 Althea Technologie...ufacturing services for biopharmaceutical products...Development to the company,s platform of services,... James Matsuura, Director of Formulation Developme...ulation and analytical scientists, along with new ...
(Date:11/5/2009)...NA, Minn., Nov. 5 ARKRAY, Inc., th...f-monitoring systems, today announced that it has ...g Administration for its new GLUCOCARD Vital blood...d strip platform, which ARKRAY will make available...o be a significant complement to the existing GLUC...
Breaking Medicine Technology:California American Water Celebrates 'No Drugs Down the Drain' Week in San Diego 2Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2ARKRAY, Inc. Receives FDA Clearance for New GLUCOCARD(R) Vital(TM) Blood Glucose Monitoring System 2Academic Opinion Leaders in the Field of Spine Surgery 26 Sacroiliac Joint Experts Attend SI BONEs National Summit on the Diagnosis of Sacroiliac Pat 57438 1Academic Opinion Leaders in the Field of Spine Surgery 26 Sacroiliac Joint Experts Attend SI BONEs National Summit on the Diagnosis of Sacroiliac Pat 57438 2Academic Opinion Leaders in the Field of Spine Surgery 26 Sacroiliac Joint Experts Attend SI BONEs National Summit on the Diagnosis of Sacroiliac Pat 57438 3Academic Opinion Leaders in the Field of Spine Surgery 26 Sacroiliac Joint Experts Attend SI BONEs National Summit on the Diagnosis of Sacroiliac Pat 57438 4Aethlon Medical Inc Announces Annual Meeting Results 14111 1Aethlon Medical Inc Announces Annual Meeting Results 14111 2Aethlon Medical Inc Announces Annual Meeting Results 14111 3Viral Genetics Lead Scientist Dr M Karen Newell Will Present at 11th Annual SoCalBio Investor and Partnership Conference 14106 1Viral Genetics Lead Scientist Dr M Karen Newell Will Present at 11th Annual SoCalBio Investor and Partnership Conference 14106 2
...ons of Body Consistent with Overall PASI ... ANTONIO, Feb. 4 Data from an integrated analysis...owed patients with moderate,to severe plaque psori...,consistently high level of skin clearance in each...upper extremities) as measured by the Psoriasis,Ar...
...copeia (Nasdaq:,PCOP), an innovator in the discove...utics, today announced that Dr. Leslie J. Browne, ...r a corporate presentation at the,BIO CEO & Invest...bruary,11-13, 2008, at The Waldorf-Astoria Hotel i...take place at 2:00 p.m. EST on Tuesday,February 12...
Other Medicine Technology:REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 2REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 3REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 4REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 5REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 6REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 7REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 8REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 9REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 10Pharmacopeia to Present at BIO CEO & Investor Conference 2008 2Pharmacopeia to Present at BIO CEO & Investor Conference 2008 3
(Date:11/8/2009)...etwork of Hispanic health advocates committed to a..., WASHINGTON, Nov. 7 ...they have heard the voice of America,s families by...t. Now the Senate must deliver, without delay, on ...d Dr. Jane L. Delgado, President and CEO of the Na...
(Date:11/8/2009)...ssage of H.R. 3961 to Secure the Stability of Medi.../ -- Statement Attributable to: J. James Rohack, M..., (Logo: http://www.newscom.com/cgi-bin/prnh/200... of the House health reform bill, which will help ...ans and calls for swift passage of H.R. 3961 to se...
(Date:11/8/2009)...hows Who Sides With Working Families vs. Insurance...ire-USNewswire/ -- On the heels of an historic lat... good, balanced health care reform bill, the Penns...ate,s U.S. representatives voted on HR 3962, the A...legislation, which passed Saturday evening by a vo...
(Date:11/7/2009)... Karen Ignagni, Presiden...P), released the following statement today on Hous...ly support comprehensive health care reform, and w... a complete overhaul of how health insurance is pr...coverage, elimination of pre-existing condition ex...
(Date:11/7/2009)...Newswire-USNewswire/ -- The American Medical Assoc...r of Health at the Family Violence Prevention Fund...y at its semi-annual policy-making meeting. The C...onor the AMA House of Delegates bestows on a non-p.../cgi-bin/prnh/20081209/AMALOGO ) ,, "Ms. Jame...
Breaking Medicine News(10 mins):Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors Family Violence Prevention Expert 2
...GTON Children who suffer traumatic brain injuries...chological problems, highlighting the need for car...published by the American Psychological Associatio...The researchers found that severe TBI can cause ma...
... Three military veterans with ALS a... from ALS (amyotrophic lateral sclerosis) have pla...ceremony sponsored by The ALS Association. , ...rom ALS (amyotrophic lateral sclerosis) have place...
... On May 12, Physicians for Human Ri...an 16 countries will hold a Global Day of Action c...es and immediately release Kamiar and Arash Alaei....there is still continuing vigilance over the unjus...
...ES, May 11 Today, (RED) and Live Nation (... an innovative slate of 26 live concerts in th...he ultimate goal of eliminating AIDS in Africa. To... and The All-American Rejects will turn o...
...Positioned to Review Medical Technology , , WASHI...me to Washington, D.C., to share their stories abo...ve their lives in advance of a May 12 U.S. House o...tion,s (FDA) preemption authority. , , "Without ...
...ment Algorithms Data from Decision Resources Allow...low Models that Better Forecast Market Share , , ... the world,s leading research and advisory firms f...nced by physician perception that the former is mo...
Other Medicine News:Health News:Traumatic brain injury haunts children for years with variety of functional problems: Two studies 2Health News:Traumatic brain injury haunts children for years with variety of functional problems: Two studies 3Health News:Traumatic brain injury haunts children for years with variety of functional problems: Two studies 4Health News:Military Veterans Struck Down by Lou Gehrig's Disease Honored on Mother's Day by The ALS Association with Wreath Laying Ceremony at Arlington National Cemetery 2Health News:Saberi Release Highlights Case of Imprisoned Iranian AIDS Doctors 2Health News:Saberi Release Highlights Case of Imprisoned Iranian AIDS Doctors 3Health News:(RED)(TM) and Live Nation Announce (RED)NIGHTS, the Concert Series to Combat AIDS in Africa 2Health News:(RED)(TM) and Live Nation Announce (RED)NIGHTS, the Concert Series to Combat AIDS in Africa 3Health News:(RED)(TM) and Live Nation Announce (RED)NIGHTS, the Concert Series to Combat AIDS in Africa 4Health News:(RED)(TM) and Live Nation Announce (RED)NIGHTS, the Concert Series to Combat AIDS in Africa 5Health News:Patients Call for Continued FDA Preemption Authority 2Health News:Patients Call for Continued FDA Preemption Authority 3Health News:Patients Call for Continued FDA Preemption Authority 4Health News:More Patients Receive Diovan As A First- Or Second-Line Therapy Compared With Cozaar or Avapro 2Health News:More Patients Receive Diovan As A First- Or Second-Line Therapy Compared With Cozaar or Avapro 3
AccuSeed Table Mount Stabilizer
SurePoint™ Stepper/Stabilizer EquipmentPortable
Prospera® Pd-103 Seeds
... BladderChek Test is the only in-office test appro.... The NMP22 BladderChek Test is a painless and non...e, that detects elevated levels of NMP22 protein. ...nts of NMP22 protein in the urine. However, the le...
Medicine Products: